Sandoz International GmbH Company Description
Sandoz makes over 5,000 different doses of generic pharmaceuticals and biotechnological drugs. As the generics arm of Swiss drug firm Novartis AG, Sandoz develops products including antibiotics and hormone therapies, as well as treatments for cardiovascular, central nervous system, and gastrointestinal disorders. Sandoz produces finished dosage forms of such off-patent drugs as Duragesic (Fentanyl) and GERD drug Prilosec. It also develops active pharmaceutical ingredients used by other companies to form finished products. Beyond the more common tablet form generics, Sandoz manufactures more complex generics in different delivery systems including patches and inhalers.
View the Comprehensive Company Description for Sandoz International GmbH
The Company Description provides a historical perspective of Sandoz International GmbH's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Sandoz International GmbH's evolution in the marketplace.
